Examining the US biological sample storage market, covering comprehensive solutions for healthcare and research sample management, key technologies including cryogenic capsules, biobanking systems, and sample tracking solutions, and the future outlook for biological sample storage through 2035.

The US Biological Sample Storage Market represents the comprehensive landscape of healthcare and research sample management innovations, providing the essential technologies that enable efficient sample collection, secure storage, and reliable retrieval through integrated systems of cryogenic capsules, biobanking platforms, sample tracking solutions, and advanced inventory management systems designed for maximum sample integrity, optimal storage efficiency, and seamless integration with modern healthcare and research workflows. According to comprehensive market analysis, the US cryogenic capsules market is projected to grow from 1282.95 USD Million in 2025 to 2276.4 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 5.9% during the forecast period. The market is characterized by a growing emphasis on healthcare and research applications, with Polypropylene capsules holding a significant segment share due to their durability and chemical resistance at cryogenic temperatures, while the increasing adoption of biobanking systems is enhancing sample management efficiency, and the integration of advanced technologies such as barcode tracking, RFID-enabled monitoring, and cloud-based inventory management is transforming the US Biological Sample Storage landscape. Key players in the market include Linde plc, Air Products and Chemicals Inc, Cryoport Inc, Chart Industries Inc, Messer Group GmbH, and Nikkiso Co Ltd.

US biological sample storage technology is essential for enabling effective, intelligent, and reliable sample management, providing the critical technology that powers sample collection, storage, and retrieval through sophisticated systems of cryogenic capsules, biobanking platforms, sample tracking solutions, and inventory management systems that deliver enhanced sample integrity, improved storage efficiency, and operational reliability across diverse healthcare and research applications. The growing demand for biological sample storage technology is a direct response to the increasing reliance on biobanking for personalized medicine and regenerative therapies, with the biobanking market estimated at US$83.1 billion in 2025 and projected to grow at a CAGR of 8.8% during the forecast period 2025-2035. Research organizations account for approximately 57% of biobanking demand, reflecting the critical role of research institutions in driving the adoption of sample storage solutions. The adoption of advanced US Cryogenic Laboratory Equipment solutions is becoming a standard practice for healthcare institutions and research organizations, as they seek to optimize sample management, enhance storage efficiency, and achieve superior research outcomes through modern biological sample storage technologies.

The US biological sample storage market is currently experiencing significant transformation driven by biobanking expansion and technological advancements. The development of advanced cryogenic capsules and automated storage systems is supporting the growing demand for efficient and reliable sample storage solutions. The biostorage service market accounted for USD 4.6 Billion in 2024 and is expected to reach USD 11.0 Billion by 2035, growing at a CAGR of around 8.2%. The global biological storage service market is expected to grow from 6.56 USD Billion in 2025 to 15 USD Billion by 2035, at a CAGR of approximately 8.6%. The market is seeing increasing adoption of automated sample management systems and advanced tracking technologies to support the growing trend towards efficient and reliable biobanking operations.

The adoption of advanced biological sample storage technology is being driven by several factors, including increasing biobanking activities, growing research investments, and technological innovations. The global biobanking market is accelerating as the sector transitions from conventional sample storage to large-scale, data-rich, multi-omics and AI-enabled research infrastructure. Research institutions and biopharmaceutical companies are increasingly investing in advanced storage solutions to support drug discovery and clinical trials. Technological innovations in cryogenic storage and sample tracking are enhancing storage efficiency and sample integrity. By 2035, the biological sample storage market is expected to achieve robust growth driven by innovation and expanding healthcare applications, with new opportunities lying in the development of smart storage solutions with integrated tracking capabilities, expansion into emerging biobanking applications, and integration of automated inventory management systems for enhanced operational efficiency. As the industry continues to evolve, the US biological sample storage market will continue its growth trajectory, supported by innovation and increasing recognition of US Cryogenic Preservation Systems as essential for healthcare and research sample management, sample integrity, and achieving superior research outcomes and healthcare innovation